Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
activities of daily living
advances in neurology
adverse drug reaction
akathisia
albumin
alcohol
alcoholism
alpha-synuclein
alternative medicine
Alzheimer's disease
Alzheimer's disease, preclinical
Alzheimer's disease, risk factors in
Alzheimer's disease, treatment of
amyloid beta protein
amyotrophic lateral sclerosis
amyotrophic lateral sclerosis, differential diagnosis
amyotrophic lateral sclerosis, etiology of
amyotrophic lateral sclerosis, prognosis
amyotrophic lateral sclerosis, treatment of
aneurysm
aneurysm, intracranial
aneurysm, intracranial, delayed cerebral ischemia with
aneurysm, intracranial, treatment of
angiotensin II receptor blocker
antibiotics
anticoagulant, treatment
anticoagulant, treatment in CVD
anticonvulsants
antihypertensive
antioxidant
apolipoprotein E
apoptosis
aptiganel
arm weakness
ascorbic acid
aspirin
atherosclerosis, generalized
autonomic dysfunction
axonal degeneration
biologic markers
BiPAP
blacks
blood pressure
body temperature
brain atrophy
brain transplantation
bulbar palsy
bulbar palsy, progressive
burning paresthesia
caffeine
calcium antagonist
calcium antagonist, side effects of
cardiac arrest
cardiac arrest and resuscitation
caspases
CAT scan
CAT scan, abnormal
CAT scan, disappearing lesion on
CAT scan, emission
CAT scan, emission, abnormal
CAT scan, xenon-enhanced
cerebral blood flow
cerebral edema
cerebral embolism
cerebral infarction
cerebral ischemia
cerebrospinal fluid
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, complications with
cerebrovascular accident, neonatal
cerebrovascular accident, pathophysiology
cerebrovascular accident, prevention of
cerebrovascular accident, prognosis in
cerebrovascular accident, severity
cerebrovascular accident, spontaneous improvement after
cerebrovascular accident, surgical treatment of
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, time of presentation
cerebrovascular accident, volume
cerebrovascular accident, work up for
cerebrovascular disease
cerebrovascular disease, risk factors in
cerebrovascular disease, surgical treatment of
cholesterol
cholesterol, LDL
cigarette smoking
citicoline
clinical trials
cognition
coma
controversies in neurology
cooling therapy
coronary artery disease
craniectomy, decompressive
crying, pathologic
DATATOP study
degenerative diseases of CNS
dementia
dementia, cerebrovascular disease causing
dementia, incidence
dementia, prevention of
dementia, treatment of
deprenyl
diabetes mellitus
diet
dimebon
disability, neurological
distal muscle weakness
dopamine agonist
dopamine receptor, D2
drug induced neurologic disorders
dying
dysarthria
dyskinesia, buccal lingual facial
dysphagia
efficacy
embolism
emergencies, neurologic
emergency medical technicians
emotional lability
encephalopathy, post traumatic
endarterectomy, carotid
endarterectomy, carotid-complications of
endarterectomy, carotid-indications for
endarterectomy, carotid-long term results
endarterectomy, carotid-morbidity and mortality with
endovascular therapy
enzyme inhibition
epidemiology of neurology
excitotoxin
fasciculation
fatigue
fever
fibrinolytic agents
fibrinolytic agents, combined IA and IV
fibrinolytic agents, contraindications
fibrinolytic agents, intra-arterial local infusion
fibroblast growth factor
fish
flavonoids
foot drop
free radical
fruits
fumarate
gadolinium
gender
Glasgow coma score
glutamic acid
head injury
head injury, evaluation of
head injury, management of
head injury, pathophysiology of
head injury, prevention
head injury, prognosis in
headache
headache, treatment of
hemodilution
hemorrhage, intracranial, newborn
hemorrhage, periventricular
heparin
heralding manifestation
herpes simplex encephalitis, diagnosis of
histamine-2 receptor blockers
HMGcoA reductase inhibitors
hormone replacement
hospice
hydrocephalus
hyperreflexia
hypertension
hyperthermia
hyperuricemia
hypotension, systemic
hypothermia
hypoxic encephalopathy
iatrogenic neurologic disorders
ibuprofen
immunomodulation
indomethacin
intellectual deficit
intracranial pressure monitoring
intraventricular hemorrhage
intrinsic hand muscles, wasting of
ischemic penumbra
Kleine-Levin syndrome
lacunar infarction
laughing, pathologic
L-dopa
leg weakness, unilateral
Lewy body
Lewy body disease, diffuse
life expectancy
lipid lowering agent
lithium
low birth weight
lubeluzole
magnesium sulfate
melatonin
mental status, evaluation of
middle cerebral artery, occlusion of
migraine, prophylaxis
migraine, treatment of
mild cognitive impairment
minocycline
monoamine oxidase inhibitors
mortality
motor neuron disease
movement disorder, extrapyramidal
MRI
MRI, abnormal
MRI, CAT scan compared to
MRI, cerebrovascular disease
MRI, contrast enhanced
MRI, diffusion weighted
MRI, early changes in CVA
MRI, false negative
MRI, mismatch between perfusion/diffusion
MRI, perfusion
MRS
multiple sclerosis
multiple sclerosis, monosymptomatic
multiple sclerosis, pathogenesis
multiple sclerosis, relapsing
multiple sclerosis, treatment of
multiple sclerosis, treatment of, first attack
muscle wasting, diffuse
N-acetyl-L-aspartic acid
nerve growth factor
neuroendocrinology
neurologic disease
neurologic disease, diagnoses of
neurologic evaluation
neurologic examination
neurologic symptoms
neurologic testing
neuronal cell death
neuropathology
neuropathology, brain
neuropathy
neuroprotective agents
neurotransmitter
nicardipine
nimodipine
NMDA antagonists
NMDA receptors
nonsteroidal anti-inflammatory drug
old age, neurology of
pallidotomy
paresthesias
paresthesias, facial
Parkinson disease
Parkinson disease, diagnosis
Parkinson disease, drug induced
Parkinson disease, early symptoms
Parkinson disease, etiology of
Parkinson disease, nonmotor problems of
Parkinson disease, pathogenesis of
Parkinson disease, prognosis of
Parkinson disease, progression
Parkinson disease, surgical treatment of
Parkinson disease, treatment of
Parkinsonism syndrome
pathology
pineal
piracetam
platelet inhibiting drugs
practice guidelines
pravastatin
preclinical
premarin
prevention of neurologic disorders
prognosis
psychological testing
rasagiline
rehabilitation for neurologic disorders
research
respirator
respiratory failure
review article
riluzole
risk factors
risk-benefit assessment
safety
seizure
seizure, treatment of
simvastatin
sinemet
single photon emission computed tomography
sleep
sleep pathology and physiology
smell
sodium-glucoe cotransporter-2 inhibitors
statin therapy
stimulant drugs
streptokinase
stroke unit
stroke, progression of
subarachnoid hemorrhage
subarachnoid hemorrhage, treatment of
subthalamic nucleus
subthalamic nucleus deep brain stimulation
synucleinopathy
tea
tetracycline
thrombolysis, mechanical
tissue plasminogen activator, intravenous
treatment of neurologic disorder
tremor, thalamic stimulation for suppression of
tripping
vasospasm, cerebral
vegetables
vestibular function, tests of
vitamin A
vitamin D
vitamin E
vitamin supplementation
whites
wine
Showing articles 1200 to 1250 of 3460 << Previous Next >>

Individual Dopaminergic Neurons Show Raised Iron Levels in Parkinson Disease
Neurol 68:1820-1825, Oakley,A.E.,et al, 2007

Aggressive Therapy for Neurosarcoidosis: Long-Term Follow-Up of 48 Treated Patients
Arch Neurol 64:691-696, Scott,T.F.,et al, 2007

Artery of Percheron Thrombolysis
AJNR 28:870-871, Kostanian,V. &Cramer,S.C., 2007

Idiopathic Transverse Myelitis. Corticosteroids, Plasma Exchange, or Cyclophosphamide
Neurol 68:1614-1617, Greenberg,B.M.,et al, 2007

Quantifying the Risks and Benefits of Natalizumab in Relapsing Multiple Sclerosis
Neurol 68:1524-1528, Dorsey,E.R.,et al, 2007

Guidelines for the Early Management of Adults With Ischemic Stroke
Stroke 38:1655-1711, Adams,H.P.,et al, 2007

MRI Outcomes in a Placebo-Controlled Trial of Natalizumab in Relapsing MS
Neurol 68:1390-1401, Miller,D.H.,et al, 2007

Usefulness of Checking Platelet Count Before Thrombolysis in Acute Ischemic Stroke
Stroke 38:1639-1640, Cucchiara,B.L.,et al, 2007

Refractory Neurosarcoidosis Responsive to Infliximab
Pract Neurol 7:112-115, Kobylecki,C. &Shaunak,S., 2007

Magnetic Resonance Perfusion Diffusion Mismatch and Thrombolysis in Acute Ischaemic Stroke: A Systematic Review of the Evidence to Date
JNNP 78:485-491,443, Kane,I.,et al, 2007

Combining Multiple Approaches for the Secondary Prevention of Vascular Events After Stroke: A Quantitative Modeling Study
Stroke 38:1881-1885,1736, Hackam,D.D. &Spence,J.D., 2007

Thrombolysis for Ischemic Stroke in Children. Data From the Natioinwide Inpatient Sample
Stroke 38:1850-1854,1722, Janjua,N.,et al, 2007

Evaluation of the Clinical-Diffusion and Perfusion-Diffusion Mismatch Models in DEFUSE
Stroke 38:1826-1830,1718, Lansberg,M.G.,et al, 2007

Estimated Cost Savings of Increased Use of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in Canada
Storke 38:1952-1955,1732, Yip,T.R. &Demaerschalk,B.M., 2007

Intermittent Cyclophosphamide With Prednisone Versus Placebo for Polyneuropathy With IgM Monoclonal Gammopathy
Neurol 69:50-59, Niermeijer,J.M.F.,et al, 2007

Emergent Combined Intracranial Thrombolysis and Carotid Stenting in the Hyperacute Management of Stroke Patients with Severe Cervical Carotid Stenosis
AJNR 28:1162-1166, Wang,H.,et al, 2007

Natalizumab for Multiple Sclerosis
NEJM 356:2622-2629, Ransohoff,R.M., 2007

Intra-arterial Therapies for Acute Ischemic Stroke
Neurol 68:2132-2139, Mandava,P. &Kent,T.A., 2007

Evidence Report: The Medical Treatment of Ocular Myasthenia (An Evidence-Based Review)
Neurol 68:2144-2149, Benatar,M. &Kaminski,H.J., 2007

Consent for Intravenous Thrombolysis in Acute Stroke
Arch Neurol 64:785-792, White-Bateman,S.R.,et al, 2007

Sirolimus-Induced Posterior Reversible Encephalopathy
Neurol 68:2039-2040, Bodkin,C.L. &Eidelman,B.H., 2007

Post-Transplant Acute Limbic Encephalitis: Clinical Features and Relationship to HHV6
Neurol 69:156-165, Seeley,W.W.,et al, 2007

Causative Factors and Epidemiology of Bilateral Vestibulopathy in 255 Patients
Ann Neurol 61:524-532, Zingler,V.C.,et al, 2007

Course of Cerebral Amyloid Angiopathy-Related Inflammation
Neurol 68:1411-1416, Kinnecom,C.,et al, 2007

Fatal Encephalopathy After an Isolated Overdose of Cocaine
JNNP 78:437-438, Kondziella,D., et al, 2007

Urgent Clinical Challenges in Children With Ischemic Stroke
Stroke 37:116-122,3, Kuhle,S.,et al, 2006

Cerebral Microbleeds on MRI
Neurol 66:165-171, Koennecke,H.-C., 2006

First-Pass Quantitiative CT Perfusion Identifies Thresholds for Salvageable Penumbra in Acute Stroke Patients Treated with Intra-arterial Therapy
AJNR 27:20-25, Schaefer,P.W.,et al, 2006

Perfusion CT Helps Decision Making for Thrombolysis When There is No Clear Time of Onset
JNNP 77:417-419, Hellier,K.D.,et al, 2006

Thrombolysis for Acute Stroke with Special Emphasis on the Very Old:Experience From a Single Dutch Centre
JNNP 77:375-377,288, van Oostenbrugge,R.J.,et al, 2006

CT and MR Imaging Findings in Methanol Intoxication
AJNR 27:452-454, Blanco,M.,et al, 2006

Linezolid-Associated Toxic Optic Neuropathy
Neurol 66:595-598, Rucker,J.C.,et al, 2006

Outcome and Symptomatic Bleeding Complications of Intravenous Thrombolysis Within 6 Hours in MRI-Selected Stroke Patients
Stroke 37:852-858, Thomalla,G.,et al, 2006

Role of CT Angiography in Thrombolysis Decision-Making for Patients with Presumed Seizure at Stroke Onset
Stroke 37:915-917, Sylaja,P.N.,et al, 2006

Therapy of Basilar Artery Occlusion, A Systematic Analysis Comparing Intra-Arterial and Intravenous Thrombolysis
Stroke 37:922-928, Lindsberg,P.J.&Mattle,H.P., 2006

What Went Wrong in the Natalizumab Trials?
Lancet 367:706-709, Langer-Gould,A.&Steinman,L., 2006

Reversible Posterior Leukoencephalopathy Syndrome and Bevacizumab
NEJM 354:980-982, Ozcan,C.,et al, 2006

Natalizumab Plus Interferon Beta -1a for Relapsing Multiple Sclerosis
NEJM 354:911-923,965, Rudick,R.A.,et al, 2006

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
NEJM 354:899-910,965, Polman,C.H.,et al, 2006

Evaluation of Patients Treated with Natalizumab for Progressive Multifocal Leukoencephalopathy
NEJM 354:924-933,965, Yousry,T.A.,et al, 2006

IM Interferon B-1a Delays Definite Multiple Sclerosis 5 Years After a First Demyelinating Event
Neurol 66:678-684, CHAMPIONS Study Group, 2006

Thrombolytic Therapy of Acute Ischemic Stroke During Pregnancy
Neurol 66:768-770, Murugappan,A.,et al, 2006

Clinicopath Conf, Diffuse Large B-Cell Lymphoma, EBV-Positive, with Immunosuppression
NEJM 354:1178-1184, Case 8-2006, 2006

Extent of Early Ischemic Changes on Computed Tomgraphy (CT) Before Thrombolysis
Stroke 37:973-978, Dzialowski,I.,et al, 2006

What is the Risk of Developing Parkinsonism Following Neuroleptic Use?
Neurol 66:941-943, Noyes,K.,et al, 2006

Imaging-Guided Acute Ischemic Stroke Therapy: From "Time is Brain" to "Physiology is Brain"
AJNR 27:728-735, Gonzalez,R.G., 2006

Neoplastic Meningitis
Neurologist 12:179-187, Chamberlain,M.C., 2006

Emerging Monoclonal Antibody Therapies for Multiple Sclerosis
Neurologist 12:171-178, Cree,B., 2006

Improvement of Postherpetic Neuralgia After Treatment With Intravenous Acyclovir Followed by Oral Valacyclovir
Arch Neurol 63:940-942, Quan,D.,et al, 2006

Axonal Polyneuropathy After Acute Dimethylamine Borane Intoxication
Arch Neurol 63:1009-1012, Kuo,H.-C.,et al, 2006



Showing articles 1200 to 1250 of 3460 << Previous Next >>